131 related articles for article (PubMed ID: 35487700)
1. Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment.
Tondo G; Boccalini C; Vanoli EG; Presotto L; Muscio C; Ciullo V; Banaj N; Piras F; Filippini G; Tiraboschi P; Tagliavini F; Frisoni GB; Cappa SF; Spalletta G; Perani D;
Neurology; 2022 Jul; 99(3):e258-e269. PubMed ID: 35487700
[TBL] [Abstract][Full Text] [Related]
2. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
3. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
[TBL] [Abstract][Full Text] [Related]
5. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
6. Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum.
Kuhn E; Perrotin A; La Joie R; Touron E; Dautricourt S; Vanhoutte M; Vivien D; de La Sayette V; Chételat G;
Neurology; 2023 Jun; 100(24):e2454-e2465. PubMed ID: 37085328
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
[TBL] [Abstract][Full Text] [Related]
8. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
[TBL] [Abstract][Full Text] [Related]
9. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
10. Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.
Bensamoun D; Guignard R; Furst AJ; Derreumaux A; Manera V; Darcourt J; Benoit M; Robert PH; David R
J Alzheimers Dis; 2016; 49(2):387-98. PubMed ID: 26484900
[TBL] [Abstract][Full Text] [Related]
11. Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients.
Yang Z; Cummings JL; Kinney JW; Cordes D;
Front Neurosci; 2023; 17():1151820. PubMed ID: 37123373
[TBL] [Abstract][Full Text] [Related]
12. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
[TBL] [Abstract][Full Text] [Related]
13. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
[TBL] [Abstract][Full Text] [Related]
14. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
[TBL] [Abstract][Full Text] [Related]
15. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
Brugnolo A; Orso B; Girtler N; Ferraro PM; Arnaldi D; Mattioli P; Massa F; Famà F; Argenti L; Biffa G; Morganti W; Buonopane S; Uccelli A; Morbelli S; Pardini M
Cortex; 2024 Feb; 171():413-422. PubMed ID: 38113612
[TBL] [Abstract][Full Text] [Related]
16. A biomarker study in long-lasting amnestic mild cognitive impairment.
Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
[TBL] [Abstract][Full Text] [Related]
17. Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
Gatchel JR; Donovan NJ; Locascio JJ; Becker JA; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
Am J Geriatr Psychiatry; 2017 Jul; 25(7):683-693. PubMed ID: 28410856
[TBL] [Abstract][Full Text] [Related]
18. The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic.
Liu F; Shi Y; Wu Q; Chen H; Wang Y; Cai L; Zhang N
CNS Neurosci Ther; 2024 Feb; 30(2):e14418. PubMed ID: 37602885
[TBL] [Abstract][Full Text] [Related]
19. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19.
Ferrucci R; Cuffaro L; Capozza A; Rosci C; Maiorana N; Groppo E; Reitano MR; Poletti B; Ticozzi N; Tagliabue L; Silani V; Priori A
J Neurol; 2023 Apr; 270(4):1823-1834. PubMed ID: 36692636
[TBL] [Abstract][Full Text] [Related]
20. Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
Shi X; Zhou N; Sun B; Wu Y; Hu Y; Ning Y;
J Alzheimers Dis; 2022; 90(3):1329-1337. PubMed ID: 36245373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]